Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Sales (2016 - 2025)

Dare Bioscience's Return on Sales history spans 7 years, with the latest figure at 1.44% for Q4 2025.

  • For Q4 2025, Return on Sales fell 8609.0% year-over-year to 1.44%; the TTM value through Dec 2025 reached 13.13%, up 239616.0%, while the annual FY2025 figure was 13.16%, 238377.0% up from the prior year.
  • Return on Sales reached 1.44% in Q4 2025 per DARE's latest filing, up from 1623.41% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 180.8% in Q2 2025 to a low of 1623.41% in Q3 2025.
  • Average Return on Sales over 4 years is 189.95%, with a median of 3.14% recorded in 2022.
  • The largest YoY upside for Return on Sales was 50879bps in 2025 against a maximum downside of -151112bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 3.14% in 2022, then increased by 9bps to 2.86% in 2023, then soared by 3060bps to 84.66% in 2024, then plummeted by -102bps to 1.44% in 2025.
  • Per Business Quant, the three most recent readings for DARE's Return on Sales are 1.44% (Q4 2025), 1623.41% (Q3 2025), and 180.8% (Q2 2025).